Literature DB >> 19663900

First positive reactions to cannabis constitute a priority risk factor for cannabis dependence.

Yann Le Strat1, Nicolas Ramoz, John Horwood, Bruno Falissard, Christine Hassler, Lucia Romo, Marie Choquet, David Fergusson, Philip Gorwood.   

Abstract

AIM: To assess the association between first reactions to cannabis and the risk of cannabis dependence.
DESIGN: A cross-sectional population-based assessment in 2007.
SETTING: A campus in a French region (Champagne-Ardennes). PARTICIPANTS: A total of 1472 participants aged 18-21 years who reported at least one life-time cannabis consumption, of 3056 students who were screened initially [the Susceptibility Addiction Gene Environment (SAGE) study]. MEASUREMENTS: Positive and negative effects of first cannabis consumptions, present cannabis dependence and related risk factors were assessed through questionnaires.
FINDINGS: The effects of first cannabis consumptions were associated dose-dependently with cannabis dependence at age 18-21 years, both according to the transversal approach of the SAGE study and to the prospective cohort of the Christchurch Health and Development Study (CHDS) assessed at the age of 25 years. Participants of the SAGE study who reported five positive effects of their first cannabis consumption had odds of life-time cannabis dependence that were 28.7 (95% confidence interval: 14.6-56.5) higher than those who reported no positive effects. This association remains significant after controlling for potentially confounding factors, including individual and familial variables.
CONCLUSIONS: This study suggests an association between positive reactions to first cannabis uses and risk of life-time cannabis dependence, this variable having a central role among, and through, other risk factors.
© 2009 The Authors. Journal compilation © 2009 Society for the Study of Addiction.

Entities:  

Mesh:

Year:  2009        PMID: 19663900     DOI: 10.1111/j.1360-0443.2009.02680.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  17 in total

1.  Subjective effects for alcohol, tobacco, and marijuana association with cross-drug outcomes.

Authors:  Joanna S Zeiger; Brett C Haberstick; Robin P Corley; Marissa A Ehringer; Thomas J Crowley; John K Hewitt; Christian J Hopfer; Michael C Stallings; Susan E Young; Soo Hyun Rhee
Journal:  Drug Alcohol Depend       Date:  2012-03-22       Impact factor: 4.492

Review 2.  Medical cannabis for chronic pain: can it make a difference in pain management?

Authors:  Mari Kannan Maharajan; Yu Jing Yong; Hong Yang Yip; Sze Shee Woon; Kar Mon Yeap; Khai Yeng Yap; Shuen Chi Yip; Kai Xian Yap
Journal:  J Anesth       Date:  2019-09-18       Impact factor: 2.078

3.  Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride.

Authors:  R E Vann; D M Walentiny; J J Burston; K M Tobey; T F Gamage; J L Wiley
Journal:  Neuropharmacology       Date:  2011-10-31       Impact factor: 5.250

4.  Subjective effects to marijuana associated with marijuana use in community and clinical subjects.

Authors:  Joanna S Zeiger; Brett C Haberstick; Robin P Corley; Marissa A Ehringer; Thomas J Crowley; John K Hewitt; Christian J Hopfer; Michael C Stallings; Susan E Young; Soo Hyun Rhee
Journal:  Drug Alcohol Depend       Date:  2010-02-09       Impact factor: 4.492

5.  Estrogen receptor 1 gene (ESR1) is associated with restrictive anorexia nervosa.

Authors:  Audrey Versini; Nicolas Ramoz; Yann Le Strat; Susann Scherag; Stefan Ehrlich; Claudette Boni; Anke Hinney; Johannes Hebebrand; Lucia Romo; Julien-Daniel Guelfi; Philip Gorwood
Journal:  Neuropsychopharmacology       Date:  2010-04-07       Impact factor: 7.853

6.  Do early experiences with cannabis vary in cigarette smokers?

Authors:  Arpana Agrawal; Pamela A F Madden; Nicholas G Martin; Michael T Lynskey
Journal:  Drug Alcohol Depend       Date:  2012-09-23       Impact factor: 4.492

Review 7.  Do initial responses to drugs predict future use or abuse?

Authors:  Harriet de Wit; Tamara J Phillips
Journal:  Neurosci Biobehav Rev       Date:  2012-04-21       Impact factor: 8.989

8.  Cdh13 and AdipoQ gene knockout alter instrumental and Pavlovian drug conditioning.

Authors:  C P King; L Militello; A Hart; C L St Pierre; E Leung; C L Versaggi; N Roberson; J Catlin; A A Palmer; J B Richards; P J Meyer
Journal:  Genes Brain Behav       Date:  2017-05-02       Impact factor: 3.449

9.  Common and drug-specific genetic influences on subjective effects to alcohol, tobacco and marijuana use.

Authors:  Brett C Haberstick; Joanna S Zeiger; Robin P Corley; Christian J Hopfer; Michael C Stallings; Soo Hyun Rhee; John K Hewitt
Journal:  Addiction       Date:  2010-10-19       Impact factor: 6.526

10.  An Examination of Marijuana Use Among a Vulnerable Population in Canada.

Authors:  Nicholas Spence; Samantha Wells; Julie George; Kathryn Graham
Journal:  J Racial Ethn Health Disparities       Date:  2014-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.